Retraction

Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma

Citations (31)

31
Total Citations
3
Post-Retraction
(9.7%)
28
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
0 After 2+ years
210 Days since retraction (latest)
Preclinical models derived from endoscopic ultrasound-guided tissue acquisition for individualized treatment of pancreatic ductal adenocarcinoma
Ting Tong, Chao Zhang, Jingbo Li et al. (5 authors)
Frontiers in Medicine Open Access
Published: Jan 2023
4 citations
210 days after retraction
Albendazole exerts an anti-hepatocellular carcinoma effect through a WWOX-dependent pathway
Tianfeng Yang, Cheng Cheng, Rui Xu et al. (9 authors)
Life Sciences
Published: Oct 2022
4 citations
130 days after retraction
Efeito do 5-AzadC em linhagem de carcinoma de células escamosas oral exposta à fibroblastos associados ao câncer
Amanda Ramos Mazzaro
Unknown Journal Open Access
Published: Aug 2022
68 days after retraction
Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
Hyun Jung Kim
Medicina Open Access
Published: May 2022
10 citations
29 days before retraction
5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line
Reem Miari, Naiel Azzam, Rinat Bar‐Shalom et al. (4 authors)
PLoS ONE Open Access
Published: Sep 2021
5 citations
265 days before retraction
Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis
Shenglong Li, Wei Wang
Frontiers in Cell and Developmental Biology Open Access
Published: Apr 2021
11 citations
434 days before retraction
Clinical efficiency of epigenetic drugs therapy in bone malignancies
Filomena de Nigris, Carlo Ruosi, Claudio Napoli
Bone
Published: Aug 2020
35 citations
658 days before retraction
Retraction Note: HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells
Paola Bendinelli, Paola Maroni, Emanuela Matteucci et al. (4 authors)
Molecular Cancer Open Access
Published: Aug 2020
664 days before retraction
Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
Xing Huang, Enliang Li, Hang Shen et al. (11 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: May 2020
62 citations
764 days before retraction
High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Si-Qi Qiu, Johan van Rooijen, Hilde H. Nienhuis et al. (11 authors)
Breast Cancer Research Open Access
Published: Mar 2020
9 citations
813 days before retraction
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K.G.K. Deepak, Rahul Kumar Vempati, Ganji Purnachandra Nagaraju et al. (7 authors)
Pharmacological Research
Published: Feb 2020
471 citations
851 days before retraction
Paper citing Epigenetic regulation of HGF/Met receptor axis is ...
Unknown Authors
Unknown Journal
Published: Dec 2019
897 days before retraction
Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
Takanori Kitamura, Yu Kato, Demi Brownlie et al. (10 authors)
Cancer Immunology Research Open Access
Published: Oct 2019
18 citations
968 days before retraction
Preclinical Modelling of PDA: Is Organoid the New Black?
Sabrina D’Agosto, Silvia Andreani, Aldo Scarpa et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2019
14 citations
1100 days before retraction
Bone Metastasis Phenotype and Growth Undergo Regulation by Micro-Environment Stimuli: Efficacy of Early Therapy with HGF or TGFβ1-Type I Receptor Blockade
Paola Bendinelli, Paola Maroni, Valentina Dall’Olio et al. (5 authors)
International Journal of Molecular Sciences Open Access
Published: May 2019
6 citations
1114 days before retraction
Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor
Katsuya Sakai, Toby Passioura, Hiroki Sato et al. (16 authors)
Nature Chemical Biology
Published: May 2019
64 citations
1119 days before retraction
Exosomes, metastases, and the miracle of cancer stem cell markers
Zhe Wang, Margot Zöller
Cancer and Metastasis Reviews
Published: Apr 2019
40 citations
1139 days before retraction
Impact of seasonality, storage of semen, and sperm head‐shape on whole tissue methylation and expression of methylation responsive candidate genes in swine placenta and fetal livers from summer and winter breedings
Lea A. Rempel, Megan M. Krautkramer, J.J. Parrish et al. (4 authors)
Molecular Reproduction and Development
Published: Feb 2019
3 citations
1211 days before retraction
Megakaryocytes in Bone Metastasis: Protection or Progression?
Paola Maroni
Cells Open Access
Published: Feb 2019
16 citations
1217 days before retraction
Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer
Jun Yin, Weimin Hu, Xingyang Xue et al. (9 authors)
Journal of Cancer Open Access
Published: Jan 2019
2 citations
1255 days before retraction
WW-Domain Containing Protein Roles in Breast Tumorigenesis
Abrar Jamous, Zaidoun Salah
Frontiers in Oncology Open Access
Published: Dec 2018
14 citations
1274 days before retraction
HGF/c-MET Signaling in Melanocytes and Melanoma
Małgorzata Czyż
International Journal of Molecular Sciences Open Access
Published: Dec 2018
82 citations
1284 days before retraction
Decitabine attenuates nociceptive behavior in a murine model of bone cancer pain
Camilla Kristine Appel, Nicole N. Scheff, Chi T. Viet et al. (5 authors)
Pain Open Access
Published: Nov 2018
14 citations
1305 days before retraction
Novel mediators of breast cancer bone metastasis—insights from studies of gene-regulation and the global proteome
Janet E. Brown, Steven L. Wood
Annals of Translational Medicine Open Access
Published: Nov 2018
1 citation
1316 days before retraction
WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions
Karolina Pospiech, Elżbieta Płuciennik, Andrzej K. Bednarek
Frontiers in Oncology Open Access
Published: Aug 2018
34 citations
1381 days before retraction
The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
Paola Maroni, Paola Bendinelli, Emanuela Matteucci et al. (4 authors)
Cell Death and Disease Open Access
Published: Apr 2018
14 citations
1508 days before retraction
Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
Lucia Demková, Lucia Kučerová
Molecular Cancer Open Access
Published: Feb 2018
69 citations
1575 days before retraction
RETRACTED: Microenvironment Stimuli HGF and Hypoxia Differently Affected miR-125b and Ets-1 Function with Opposite Effects on the Invasiveness of Bone Metastatic Cells: A Comparison with Breast Carcinoma Cells
Emanuela Matteucci, Paola Maroni, Francesco Nicassio et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Jan 2018
5 citations
1605 days before retraction
In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas
Paola Maroni, Rossella Puglisi, Gianfranco Mattia et al. (7 authors)
Carcinogenesis Open Access
Published: Mar 2017
27 citations
1912 days before retraction
Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors
Paola Maroni, Emanuela Matteucci, Paola Bendinelli et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Jan 2017
21 citations
1985 days before retraction
Quick Stats
Total Citations: 31
Years Since Retraction: 3.4 years
Open Access: Yes
Last Checked: Jul 24, 2025